Abstract
High levels of psychotropic medication use and polypharmacy are common for emotionally and behaviorally troubled youth entering residential care. Polypharmacy has often been characterized as an especially serious problem in this vulnerable population. Latent Class Analysis was used to identify medication subgroups for 636 youth in an intensive residential program. Additionally, auxiliary analyses (e.g., diagnoses, demographics, expressed problem behaviors) were used to identify the personal and behavioral attributes associated with individuals in each of the latent classes. Three distinct medication patterns emerged: low/no psychotropic medication, the combination of antidepressant and antipsychotic medications, and multiple psychotropic medications. The latent classes were significantly different from one another on 12 of the 14 variables, helping explicate how patient and clinical characteristics underlie patterns of psychotropic medication use. Findings of this study, combined with additional research, hold promise for leading to improved, youth-centered prescribing practices. Our findings also highlight the need for careful monitoring of the types and range of medications that some youth are prescribed, and research on how youth with certain background characteristics are more likely to get prescribed multiple psychotropic medications. For youth experiencing higher levels of psychotropic polypharmacy, medication regimens need thoughtful reassessment using the principle of sufficiency as the foundation for medication management.
Similar content being viewed by others
References
Aman, M. G., Lam, K. S. L., & Van Bourgondien, M. E. (2005). Medication patterns in patients with autism: Temporal, regional, and demographic influences. Journal of Child and Adolescent Psychopharmacology, 15, 116–126. doi:10.1089/cap.2005.15.116.
Anda, R. F., Brown, D. W., Felitti, V. J., Bremner, J. D., Dube, S. R., & Giles, W. H. (2007). Adverse childhood experiences and prescribed psychotropic medications in adults. American Journal of Preventive Medicine, 32, 389–394. doi:10.1016/j.amepre.2007.01.005.
Asparouhov, T., & Muthén, B. (2014a). Auxiliary variables in mixture modeling: Three-step approaches using Mplus. Structural Equation Modeling: A Multidisciplinary Journal, 21, 329–341.
Asparouhov, T., & Muthén, B. (2014b). Auxiliary variables in mixture modeling: Using the BCH method in Mplus to estimate a distal outcome model and an arbitrary secondary model. (Mplus Web Notes: No. 21).
Bellonci, C., & Huefner, J. C. (2014). Best medication practices within residential treatment centers for children and adolescents. In E. Caldwell, R. E. Lieberman, & G. M. Blau (Eds.), Best practices in residential: A roadmap to improve long-term outcomes (pp. xx).
Bennink, M., Croon, M. A., & Vermunt, J. K. (2013). Micro-macro multilevel analysis for discrete data: A latent variable approach and an application on personal network data. Sociological Methods and Research, 42, 431–457.
Berlin, K. S., Parra, G. R., & Williams, N. A. (2014). An introduction to latent variable mixture modeling (part 2): Longitudinal latent class growth analysis and growth mixture models. Journal of Pediatric Psychology, 39, 188–203.
Brack, A. B., Huefner, J. C., & Handwerk, M. L. (2012). The impact of abuse and gender on psychopathology, behavioral disturbance, and psychotropic medication count for youth in residential treatment. American Journal of Orthopsychiatry, 82, 562–572. doi:10.1111/j.1939-0025.2012.01177.x.
Breland-Noble, A. M., Elbogen, E. B., Farmer, E. M. Z., Dubs, M. S., Wagner, H. R., & Burns, B. J. (2004). Use of psychotropic medications by youths in therapeutic foster care and group homes. Psychiatric Services, 55, 706–708. doi:10.1176/appi.ps.55.6.706.
Brüggemann, B. R., Elgeti, H., & Ziegenbein, M. (2008). Patterns of drug prescription in a psychiatric outpatient care unit: The issue of polypharmacy. German Journal of Psychiatry, 11, 1–6.
Brunner, E., Tohen, M., Osuntokun, O., Landry, J., & Thase, M. E. (2014). Efficacy and safety of olanzapine/fluoxetine combination vs fluoxetine monotherapy following successful combination therapy of treatment-resistant major depressive disorder. Neuropsychopharmacology, 39, 2549–2559. doi:10.1038/npp.2014.101.
Burcu, M., Zito, J. M., Safer, D. J., & Ibe, A. (2014). Psychotropic medication patterns in Medicaid-insured youth based on clinician-reported maltreatment status. Journal of Child and Family Studies, 23, 632–640. doi:10.1007/s10826-013-9713–6.
Carlson, G. A., Potegal, M., Margulies, D., Gutkovich, Z., & Basile, J. (2009). Rages - What are they and who has them?. Journal of Child and Adolescent Psychopharmacology, 19, 281–288. doi:10.1089/cap.2008.0108.
Chamberlain, P., Price, J. M., Reid, J. B., Landsverk, J., Fisher, P. A., & Stoolmiller, M. (2006). Who disrupts from placement in foster and kinship care?. Child Abuse & Neglect, 30, 409–424.
Chamberlain, P., & Reid, J. B. (1987). Parent observation and report of child symptoms. Behavioral Assessment, 9, 97–109.
Chena, J., Gao, K., & Kemp, D. E. (2011). Second-generation antipsychotics in major depressive disorder: Update and clinical perspective. Current Opinion in Psychiatry, 24, 10–17. doi:10.1097/YCO.0b013e3283413505.
Comer, J. S., Olfson, M., & Mojtabai, R. (2010). National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996–2007. Journal of the American Academy of Child & Adolescent Psychiatry, 49, 1001–1010. doi:10.1016/j.jaac.2010.07.007.
Connor, D. F., Ozbayrak, K. R., Harrison, R. J., & Melloni, R. H. J. (1998). Prevalence and patterns of psychotropic and anticonvulsant medication use in children and adolescents referred to residential treatment. Journal of Child and Adolescent Psychopharmacology, 8, 27–38. doi:10.1016/S0031-9384(96)00373-3.
Correll, C. U., & Carlson, H. E. (2006). Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. Journal of the American Academy of Child & Adolescent Psychiatry, 45, 771–791. doi:10.1097/01.chi.0000220851.94392.30.
Daly, D. L., & Davis, J. L. (2003). Long-term residential program training manual. Boys Town, NE: Boys Town Press.
Daly, D. L., Schmidt, M. D., Spellman, D. F., Criste, T. R., Dinges, K., & Teare, J. F. (1998). The Boys Town Residential Treatment Center: Treatment implementation and preliminary outcomes. Child & Youth Care Forum, 27, 267–279.
Dean, A. J., McDermott, B. M., & Marshall, R. T. (2006). Psychotropic medication utilization in a child and adolescent mental health service. Journal of Child and Adolescent Psychopharmacology, 16, 273–285. doi:10.1089/cap.2006.16.273.
Felitti, V. J., Anda, R. F., Nordenberg, D., Williamson, D. F., Spitz, A. M., & Edwards, V. (1998). Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: The Adverse Childhood Experiences (ACE) Study. American Journal of Preventive Medicine, 14, 245–258.
Findling, R. L., Horwit, S. M., Birmaher, B., Kowatch, R. A., Fristad, M. A., Youngstrom, E. A., & Marks, S. J. (2011). Clinical characteristics of children receiving antipsychotic medication. Journal of Child and Adolescent Psychopharmacology, 21, 311–319. doi:10.1089/cap.2010.0138.
Fite, P. J., Stoppelbein, L., Greening, L., & Dhossche, D. (2008). Child internalizing and externalizing behavior as predictors of age at first admission and risk for repeat admission to a child inpatient facility. American Journal of Orthopsychiatry, 78, 63–69. doi:10.1037/0002-9432.78.1.63.
Fontanella, C. A., Bridge, J. A., & Campo, J. V. (2009). Psychotropic medication changes, polypharmacy, and the risk of early readmission in suicidal adolescent inpatients. The Annals of Pharmacotherapy, 43, 1939–1947. doi:10.1345/aph.1M326.
Fossett, J. W., Perloff, J. D., Kletke, P. R., & Peterson, J. A. (1992). Medicaid and access to child health care in Chicago. Journal of Health Politics, Policy and Law, 17, 273–289. doi:10.1215/03616878-17-2-273.
Gadow, K. D., Brown, N. V., Arnold, L. E., Buchan-Page, K. A., Bukstein, O. G., Butter, E., & Aman, M. G. (2016). Severely aggressive children receiving stimulant medication versus stimulant and risperidone: 12-month follow-up of the TOSCA trial. Journal of the American Academy of Child & Adolescent Psychiatry, 55, 469–478. doi:10.1016/j.jaac.2016.03.014.
GAO. (2011). Foster children: HHS guidance could help states improve oversight of psychotropic prescriptions (GAO-12-270T). Washington, DC: U.S. Government Accountability Office.
Green, T. C., Kershaw, T., Lin, H., Heimer, R., Goulet, J. L., Kraemer, K. L., & Justice, A. C. (2010). Patterns of drug use and abuse among aging adults with and without HIV: A latent class analysis of a US veteran cohort. Drug and Alcohol Dependence, 110, 208–220. doi:10.1016/j.drugalcdep.2010.02.020.
Griffith, A. K., Huscroft-D’Angelo, J., Epstein, M. H., Singh, N. N., Huefner, J. C., & Pick, R. (2010). Psychotropic medication use for youth in residential treatment: A comparison between youth with monopharmacy versus polypharmacy. Journal of Child and Family Studies, 19, 795–802. doi:10.1007/s10826-010-9372-9.
Harrison, J. N., Cluxton-Keller, F., & Gross, D. (2012). Antipsychotic medication prescribing trends in children and adolescents. Journal of Pediatric Health Care, 26, 139–145. doi:10.1016/j.pedhc.2011.10.009.
Hedden, S. L., Martins, S. S., Malcolm, R. J., Floyd, L., Cavanaugh, C. E., & Latimer, W. W. (2010). Patterns of illegal drug use among an adult alcohol dependent population: Results from the National Survey on Drug Use and Health. Drug and Alcohol Dependence, 106, 119–125. doi:10.1016/j.drugalcdep.2009.08.002.
Holm, S. (1979). A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics, 6, 65–70.
Huefner, J. C., Griffith, A. K., Smith, G. L., Vollmer, D. G., & Leslie, L. K. (2014). Reducing psychotropic medications in an intensive residential treatment center. Journal of Child and Family Studies, 23, 675–685. doi:10.1007/s10826-012-9628-7.
Huefner, J. C., & Vollmer, D. G. (2014). Characteristics and treatment needs of preadolescent versus adolescent children in an intensive residential treatment program. Residential Treatment for Children & Youth, 31, 301–315.
Ippen, C. G., Harris, W. W., van Horn, P., & Lieberman, A. F. (2011). Traumatic and stressful events in early childhood: Can treatment help those at highest risk? Child Abuse & Neglect, 35, 504–513. doi:10.1016/j.chiabu.2011.03.009.
Jann, M. W., Penzak, S. R., & Cohen, L. J. (2016). Applied clinical pharmacokinetics and pharmacodynamics of psychopharmacological agents. Cham, Switzerland: Springer.
Jobe-Shields, L., Parra, G. R., Williams, N. A., & Andrews, A. (2015). Person-centered approaches to understanding early family risk. Journal of Family Theory & Review.
Kingsbury, S. J., Yi, D., & Simpson, G. M. (2001). Rational and irrational polypharmacy. Psychiatric Services, 52, 1033–1035. doi:10.1176/appi.ps.52.8.1033.
Lanza, S. T., Flaherty, B. P., & Collins, L. M. (2003). Latent class and latent transition analysis. Handbook of psychology: Research methods in psychology (pp. 663–685). Hoboken, NJ, US: John Wiley & Sons Inc. Vol. 2
Larzelere, R. E. (1996). Inter-coder reliabilities and construct groupings for some important codes on the Daily Incident Report (Tech. Report No. 004–96). Boys Town, NE: Father Flanagan’s Boys’ Home.
Leibenluft, E. (2011). Severe mood dysregulation, irritability, and the diagnostic boundaries of bipolar disorder in youths. The American Journal of Psychiatry, 168, 129–142. doi:10.1176/appi.ajp.2010.10050766.
Leslie, L. K., Weckerly, J., Landsverk, J., Hough, R. L., Hurlburt, M. S., & Wood, P. A. (2003). Racial/ethnic differences in the use of psychotropic medication in high-risk children and adolescents. Journal of the American Academy of Child & Adolescent Psychiatry, 42, 1433–1442. doi:10.1097/00004583-200312000-00010.
Li, Q., Xiang, Y. T., Su, Y. A., Shu, L., Yu, X., Chiu, H. F. K., & Si, T. M. (2015). Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: Findings of the third national survey on use of psychotropic medications in China. Australian and New Zealand Journal of Psychiatry, 49, 129–136. doi:10.1177/0004867414536931.
Linton, D., Barr, A. M., Honer, W. G., & Procyshyn, R. M. (2013). Antipsychotic and psychostimulant drug combination therapy in attention deficit/hyperactivity and disruptive behavior disorders: A systematic review of efficacy and tolerability. Current Psychiatry Reports, 15, 1–11. doi:10.1007/s11920-013-0355-6.
Logan, S. L., Carpenter, L., Leslie, R. S., Garrett-Mayer, E., Hunt, K. J., Charles, J., & Nicholas, J. S. (2015). Aberrant behaviors and co-occurring conditions as predictors of psychotropic polypharmacy among children with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 25, 323–336. doi:10.1089/cap.2013.0119.
Lyons, J. S., MacIntyre, J. C., Lee, M. E., Carpinello, S., Zuber, M. P., & Fazio, M. L. (2004). Psychotropic medications prescribing patterns for children and adolescents in New York’s public mental health system. Community Mental Health Journal, 40, 101-118. doi:10.1023/B:COMH.0000022731.65054.3e.
Marcus, R. N., McQuade, R. D., Carson, W. H., Hennicken, D., Fava, M., Simon, J. S., & Berman, R. M. (2008). The efficacy and safety of Aripiprazole as adjunctive therapy in major depressive disorder: A second multicenter, randomized, double-blind, placebo-controlled study. Journal of Clinical Psychopharmacology, 28, 156-165.
Martin, A., Van Hoof, T., Stubbe, D., Sherwin, T., & Scahill, M. C. (2003). Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid managed care. Psychiatric Services, 54, 72–77. doi:10.1176/appi.ps.54.1.72.
McIntyre, R. S., & Jerrell, J. M. (2009). Polypharmacy in children and adolescents treated for major depressive disorder: A claims database study. Journal of Clinical Psychiatry, 70, 240–246. doi:10.4088/JCP.08m04212.
Mojtabai, R., & Olfson, M. (2010). National trends in psychotropic medication polypharmacy in office-based psychiatry. Archives of General Psychiatry, 67, 26–36. doi:10.1001/archgenpsychiatry.2009.175.
Muthén, L. K., & Muthén, B. O. (2012). Mplus User’s Guide. Seventh Edition Los Angeles: Muthén & Muthén.
Olfson, M., Crystal, S., Gerhard, T., Huang, C. S., & Carlson, G. A. (2009). Mental health treatment received by youths in the year before and after new diagnosis of bipolar disorder. Psychiatric Services, 60, 1098–1106. doi:10.1176/appi.ps.60.8.1098.
Olfson, M., Crystal, S., Huang, C., & Gerhard, T. (2010). Trends in antipsychotic drug use by very young, privately insured children. Journal of the American Academy of Child & Adolescent Psychiatry, 49, 13–23. doi:10.1097/00004583-201001000-00005.
Papakostas, G. I. (2010). Switching, combination, and augmentation strategies for major depressive disorder. Annals of Clinical Psychiatry, 22, S9–S14.
Pappadopulos, E., MacIntyre, J. C., Crismon, M. L., Findling, R. L., Malone, R. P., Derivan, A., & Jensen, P. S. (2003). Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II. Journal of the American Academy of Child & Adolescent Psychiatry, 42, 145–161. doi:10.1097/00004583-200302000-00008.
Patra, J., Fischer, B., Maksimowska, S., & Rehm, J. (2009). Profiling poly-substance use typologies in a multi-site cohort of illicit opioid and other drug users in Canada - A latent class analysis. Addiction Research & Theory, 17, 168–185. doi:10.1080/16066350802372827.
Pruitt, D. B., & Kiser, L. J. (2004). Examining pediatric multipsychotropic regimens. Behavioral Health Management, 24, S1–S4.
Radigan, M., Lannon, P., Roohan, P., & Gesten, F. (2005). Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population. Journal of Child and Adolescent Psychopharmacology, 15, 44–56.
Raghavan, R., Brown, D. S., Allaire, B. T., Garfield, L. D., Ross, R. E., & Snowden, L. R. (2014). Racial/ethnic differences in Medicaid expenditures on psychotropic medications among maltreated children. Child Abuse & Neglect, 38, 1002–1010. doi:10.1016/j.chiabu.2014.02.013.
Raghavan, R., & McMillen, J. C. (2008). Use of multiple psychotropic medications among adolescents aging out of foster care. Psychiatric Services, 59, 1052–1055.
Ramo, D. E., Grov, C., Delucchi, K., Kelly, B. C., & Parsons, J. T. (2010). Typology of club drug use among young adults recruited using time-space sampling. Drug and Alcohol Dependence, 107, 119–127. doi:10.1016/j.drugalcdep.2009.09.014.
Rawal, P. H., Lyons, J. S., MacIntyre, II, J. C., & Hunter, J. C. (2004). Regional variation and clinical indicators of antipsychotic use in residential treatment: A four-state comparison. Journal of Behavioral Health Services & Research, 31, 178–188.
Ringle, J. L., Huefner, J. C., James, S., Pick, R., & Thompson, R. W. (2012). 12-month follow-up outcomes for youth departing an integrated residential continuum of care. Children and Youth Services Review, 34, 675–679. doi:10.1016/j.childyouth.2011.12.013.
Rosenheck, R. (2005). The growth of psychopharmacology in the 1990s: Evidence-based practice or irrational exuberance. International Journal of Law and Psychiatry, 28, 467–483.
Rubin, D., Matone, M., Huang, Y. S., dosReis, S., Feudtner, C., & Localio, R. (2012). Interstate variation in trends of psychotropic medication use among Medicaid-enrolled children in foster care. Children and Youth Services Review, 34, 1492–1499. doi:10.1016/j.childyouth.2012.04.006.
Ryan, J. B., Reid, R., Gallagher, K., & Ellis, C. (2008). Prevalence rates of psychotropic medications for students placed in residential facilities. Behavioral Disorders, 33, 99–107.
Safer, D. J., Zito, J. M., & dosReis, S. (2003). Concomitant psychotropic medication for youths. The American Journal of Psychiatry, 160, 438–449. doi:10.1176/appi.ajp.160.3.438.
Saldaña, S. N., Keeshin, B. R., Wehry, A. M., Blom, T. J., Sorter, M. T., DelBello, M. P., & Strawn, J. R. (2014). Antipsychotic polypharmacy in children and adolescents at discharge from psychiatric hospitalization. Pharmacotherapy, 34, 836–844. doi:10.1002/phar.1453.
Schilling, S., & Christian, C. W. (2014). Child physical abuse and neglect. Child and Adolescent Psychiatric Clinics of North America, 23, 309–319. doi:10.1016/j.chc.2014.01.001.
Singh, M. K., & Chang, K. D. (2012). The neural effects of psychotropic medications in children and adolescents. Child and Adolescent Psychiatric Clinics of North America, 21, 753–771. doi:10.1016/j.chc.2012.07.010.
Smith, B. D. (2005). Self-mutilation and pharmacotherapy. Psychiatry, 2, 29–37.
Spellman, D. F., Griffith, A. K., Huefner, J. C., Wise, III, N., McElderry, E., & Leslie, L. K. (2010). Psychotropic medication management in a residential group care program. Child Welfare, 89, 151–167.
Stambaugh, L. F., Leslie, L. K., Ringeisen, H., Smith, K., & Hodgkin, D. (2012). Psychotropic medication use by children in child welfare. (OPRE Report #2012–33). Washington, DC: Office of Planning, Research and Evaluation, ACF, DHHS.
Steiner, H., & Karnik, N. S. (2009). Integrated treatment of aggression in the context of ADHD in children refractory to stimulant monotherapy: A window into the future of child psychopharmacology. The American Journal of Psychiatry, 166, 1315–1317. doi:10.1176/appi.ajp.2009.09101496.
Taylor, D. (2010). Antipsychotic polypharmacy - confusion reigns. The Psychiatrist, 34, 41–43.
Tishler, C. L., & Reiss, N. S. (2012). Psychotropic drugs and paediatrics: A critical need for more clinical trials. Journal of Medical Ethics, 38, 250–252. doi:10.1136/medethics-2011-100003.
Vitiello, B. (2005). Pharmacoepidemiology and pediatric psychopharmacology research. Journal of Child and Adolescent Psychopharmacology, 15, 10–11. doi:10.1089/cap.2005.15.10.
Vitiello, B. (2007). Research in child and adolescent psychopharmacology: Recent accomplishments and new challenges. Psychopharmacology, 191, 5–13. doi:10.1007/s00213-006-0414-3.
Wilens, T. E. (2009). Combined pharmacotherapy in pediatric psychopharmacology: Friend or foe?. Journal of Child and Adolescent Psychopharmacology, 19, 483–484. doi:10.1089/cap.2009.19501;10.1089/cap.2009.19501.
Wright, D. J. (2001). The relationship of anxiety and externalizing disorders. Dissertation Abstracts International: Section B: The Sciences and Engineering, 62, 2084B.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No external funding supported any aspect of this study. None of the authors has any conflicting interest.
Research Involving Human Participants and/or Animals
The research protocols were reviewed and approved by the organization’s internal review board (IRB) according to federal guidelines (as mentioned in the manuscript in the Procedure section).
Informed Consent
This research was based on archival data and so informed consent was not required by the IRB.
Rights and permissions
About this article
Cite this article
Huefner, J.C., Smith, G.L., Ringle, J.L. et al. Patterns of Psychotropic Medication at Admission for Youth in Residential Care. J Child Fam Stud 26, 317–328 (2017). https://doi.org/10.1007/s10826-016-0548-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10826-016-0548-9